Lincoln (Lincoln Pharmaceutical Ltd.)


Welcome to the PulseAid listing for the Lincoln drug offered from Lincoln Pharmaceutical Ltd.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Lincoln Pharmaceutical Ltd.
NON-PROPRIETARY NAME: Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
SUBSTANCE NAME: POLYMYXIN B SULFATE; NEOMYCIN SULFATE; BACITRACIN ZINC
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2013-05-17
END MARKETING DATE: 0000-00-00


Lincoln HUMAN OTC DRUG Details:

Item DescriptionLincoln from Lincoln Pharmaceutical Ltd.
LABELER NAME: Lincoln Pharmaceutical Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 5000; 3.5; 400([USP’U]/g; mg/g; [USP’U]/g)
START MARKETING DATE: 2013-05-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69636-3025_2fae7dd2-1d16-0459-e054-00144ff88e88
PRODUCT NDC: 69636-3025
APPLICATION NUMBER: part333B

Other POLYMYXIN B SULFATE; NEOMYCIN SULFATE; BACITRACIN ZINC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Chain Drug Marketing Association Inc.Triple Antibiotic
Davemed Healthcare Co., Ltd.Triple Antiobiotic
Lincoln Pharmaceutical Ltd.Lincoln
Sabel Med LLCAftate Triple Antibiotic
Valu Merchandisers, Co.Triple Antibiotic